Real-time enrollment status for this focal seizure clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 5:56 PM UTC
| NCT Number | NCT07563881 |
| Recruiting Status | Recruiting |
| Condition | Focal Seizure |
| Phase | PHASE3 |
| Target Enrollment | 333 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Rapport Therapeutics Inc. |
| Last Updated on CT.gov | June 16, 2026 (Jun 16, 2026) |
As of July 17, 2026: Clinical trial NCT07563881 is currently recruiting participants. This phase3 study for focal seizure is actively seeking new participants at 3 locations across the United States. The study is sponsored by Rapport Therapeutics Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07563881 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07563881 was last updated Jun 16, 2026 (June 16, 2026). HelloStudys verifies this status automatically.